52.14
4.16%
2.08
アフターアワーズ:
52.55
0.41
+0.79%
Corcept Therapeutics Inc (CORT) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
8.42%
146.81
|
135.41 | 123.60 | 117.72 | 105.65 |
Cost Of Revenue |
35.06%
2.535
|
1.877 | 1.645 | 1.574 | 1.386 |
Gross Profit |
8.05%
144.27
|
133.53 | 121.96 | 116.14 | 104.27 |
Operating Expenses
|
12.68%
114.77
|
101.86 | 90.78 | 86.56 | 89.42 |
Benefits Costs and Expenses |
13.41%
111.81
|
98.60 | 87.22 | 84.78 | 87.22 |
Costs And Expenses |
13.08%
117.31
|
103.74 | 92.42 | 88.13 | 90.80 |
Operating Income/Loss |
6.85%
29.50
|
31.67 | 31.18 | 29.58 | 14.85 |
Nonoperating Income/Loss |
6.87%
5.493
|
5.14 | 5.208 | 3.347 | 3.581 |
Income/Loss From Continuing Operations Before Tax |
4.93%
34.99
|
36.81 | 36.38 | 32.93 | 18.43 |
Income Tax Expense/Benefit, Deferred |
95.04%
-7.162
|
-3.672 | -8.857 | -10.24 | -6.726 |
Income Tax Expense/Benefit |
32.58%
7.231
|
5.454 | 5.007 | 5.402 | 2.555 |
Income/Loss From Continuing Operations After Tax |
11.46%
27.76
|
31.36 | 31.38 | 27.53 | 15.88 |
Net Income/Loss
|
11.46%
27.76
|
31.36 | 31.38 | 27.53 | 15.88 |
Preferred Stock Dividends And Other Adjustments |
16.98%
0.248
|
0.212 | 0.206 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
27,658%
102.79
|
-0.373 | 102.01 | 101.96 | 107.89 |
Diluted Average Shares |
35,329%
109.92
|
-0.312 | 111.10 | 109.59 | 115.42 |
Basic Earnings Per Share |
10.00%
0.27
|
0.30 | 0.31 | 0.27 | 0.15 |
Diluted Earnings Per Share |
10.71%
0.25
|
0.28 | 0.28 | 0.25 | 0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
16.98%
0.248
|
0.212 | 0.206 | - | - |
大文字化:
|
ボリューム (24 時間):